AAAAAA

   
Results: 1-11 |
Results: 11
LATANOPROST TREATMENT FOR GLAUCOMA - EFFECTS OF TREATING FOR 1 YEAR AND OF SWITCHING FROM TIMOLOL
Authors: CAMRAS CB WAX MB RITCH R WEINREB R ROBIN AL HIGGINBOTHAM EJ LUSTGARTEN J STEWART WC SHERWOOD M KRUPIN T WILENSKY J CIOFFI GA KATZ LJ SCHUMER RA KAUFMAN PL MINCKLER D ZIMMERMAN T STJERNSCHANTZ J
Citation: Cb. Camras et al., LATANOPROST TREATMENT FOR GLAUCOMA - EFFECTS OF TREATING FOR 1 YEAR AND OF SWITCHING FROM TIMOLOL, American journal of ophthalmology, 126(3), 1998, pp. 390-399
IDENTIFICATION OF HER-2 NEU CTL EPITOPES USING DOUBLE TRANSGENIC MICEEXPRESSING HLA-A2.1 AND HUMAN CD.8/
Authors: LUSTGARTEN J THEOBALD M LABADIE C LAFACE D PETERSON P DISIS ML CHEEVER MA SHERMAN LA
Citation: J. Lustgarten et al., IDENTIFICATION OF HER-2 NEU CTL EPITOPES USING DOUBLE TRANSGENIC MICEEXPRESSING HLA-A2.1 AND HUMAN CD.8/, Human immunology, 52(2), 1997, pp. 109-118
TOLERANCE TO P53 BY A2.1-RESTRICTED CYTOTOXIC T-LYMPHOCYTES
Authors: THEOBALD M BIGGS J HERNANDEZ J LUSTGARTEN J LABADIE C SHERMAN LA
Citation: M. Theobald et al., TOLERANCE TO P53 BY A2.1-RESTRICTED CYTOTOXIC T-LYMPHOCYTES, The Journal of experimental medicine, 185(5), 1997, pp. 833-841
REDIRECTING EFFECTOR LYMPHOCYTES USING CHIMERIC RECEPTORS WITH ANTIBODY SPECIFICITY - NEW APPROACH FOR IMMUNO-GENE THERAPY OF CANCER
Authors: ESHHAR Z WAKS T GROSS G LUSTGARTEN J BACH N FITZERATTAS CJ RATNER A SCHINDLER DG
Citation: Z. Eshhar et al., REDIRECTING EFFECTOR LYMPHOCYTES USING CHIMERIC RECEPTORS WITH ANTIBODY SPECIFICITY - NEW APPROACH FOR IMMUNO-GENE THERAPY OF CANCER, Journal of clinical biochemistry and nutrition, 21(1), 1996, pp. 86-87
THE T-BODY APPROACH - POTENTIAL FOR CANCER-IMMUNOTHERAPY
Authors: ESHHAR Z BACH N FITZERATTAS CJ GROSS G LUSTGARTEN J WAKS T SCHINDLER DG
Citation: Z. Eshhar et al., THE T-BODY APPROACH - POTENTIAL FOR CANCER-IMMUNOTHERAPY, Perspectives in mathematical logic, 18(2), 1996, pp. 199-209
LATANOPROST, A PROSTAGLANDIN ANALOG, FOR GLAUCOMA THERAPY - EFFICACY AND SAFETY AFTER 1 YEAR OF TREATMENT IN 198 PATIENTS
Authors: CAMRAS CB ALM A WATSON P STJERNSCHANTZ J AASVED H JANGARD P LUNDANDERSEN H FLESNER P SODERSTROM M EHINGER B HOLMIN C BENGTSSONSTIGMAR E HEIJL A GUNDERSEN KG AIRAKSINEN J TUULONEN A HALSEIDE R LINDBLOM B RINGVOLD A VEGGE T LINDEN C NILSSON SE FRISTROM B WIDENGARD I THYGESEN J GREEN F VALENZUELA F POTTS M SPENCER I COAKES R REYNOLDS P MILLS B CHATTERJEE A NAGASUBRAMANIAN S ROXBURGH S SANDERS R BAILEY M WHYTE IF VERNON S SLOPER M MURRAY S DAVEY C HICKMANCASEY J LONGSTAFF S CURRIE Z WISHART P AUSTIN M BIRCH M ELKINGTON A LUFF A BECK L BLACKMORE M CIOFFI GA VANBUSKIRK EM FRASER J STEWART JA LUSTGARTEN J SCHUMER RA PODOS SM ARROYO M NITZBERG S RITCH R ABUNDO G CARONIA R LIEBMANN J STEINBERGER D KRUPIN T ROSENBERG LF RUDERMANN JM CLARKSON K WEINREB R OCHABSI R SHERWOOD M SMITH MF STOKES DW ZAM ZA WILENSKY J HILLMAN D KAPLAN B GATES V NAIL C ZIMMERMAN T FECHTNER R FENTON R FENTON J HIGGINBOTHAM EJ JOHNSON AT POLLACKRUNDLE CJ WEISS E YABLONSKI ME TANNENBAUM MH IBRAHIM F OHIA E NEELEY D MINCKLER D HEUER D LEE P PADEA M KAUFMAN PL HEATLEY GA VANDERHOFYOUNG MA WAX M JONES A KATZ LJ MOSTER M PARKER B ROBIN AL JUZYCH M BRUMMETT M
Citation: Cb. Camras et al., LATANOPROST, A PROSTAGLANDIN ANALOG, FOR GLAUCOMA THERAPY - EFFICACY AND SAFETY AFTER 1 YEAR OF TREATMENT IN 198 PATIENTS, Ophthalmology, 103(11), 1996, pp. 1916-1924
COMPARISON OF LATANOPROST AND TIMOLOL IN PATIENTS WITH OCULAR HYPERTENSION AND GLAUCOMA - A 6-MONTH, MASKED, MULTICENTER TRIAL IN THE UNITED-STATES
Authors: CAMRAS CB CIOFFI GA VANBUSKIRK EM FRASER J STEWART WC STEWART JA LUSTGARTEN J SCHUMER RA PODOS SM ARROYO M NITZBERG S RITCH R ABUNDO G CARONIA R LIEBMANN J STEINBERGER D KRUPIN T ROSENBERG LF RUDERMAN JM CLARKSON K WEINREB RN OCHABSI R SHERWOOD M SMITH MF STOKES DW ZAM ZS WILENSKY J HILLMAN D KAPLAN B GATES V NAIL C ZIMMERMAN T FECHTNER R FENTON R FENTON J HIGGINBOTHAM EJ JOHNSON AT POLLACKRUNDLE CJ WEISS E YABLONSKI ME TANNENBAUM MH IBRAHIM F OHIA E NEELY D MINCKLER D HEUER D LEE P PADEA M KAUFMAN PL HEATLEY GA VANDERHOFYOUNG MA WAX M JONES A KATZ LJ MOSTER M PARKER B ROBIN AL JUZYCH M BRUMMETT M PARKHEDE U
Citation: Cb. Camras et al., COMPARISON OF LATANOPROST AND TIMOLOL IN PATIENTS WITH OCULAR HYPERTENSION AND GLAUCOMA - A 6-MONTH, MASKED, MULTICENTER TRIAL IN THE UNITED-STATES, Ophthalmology, 103(1), 1996, pp. 138-147
PROLONGED INHIBITION OF IGE PRODUCTION IN MICE FOLLOWING TREATMENT WITH AN IGE-SPECIFIC IMMUNOTOXIN
Authors: LUSTGARTEN J WAKS T ESHHAR Z
Citation: J. Lustgarten et al., PROLONGED INHIBITION OF IGE PRODUCTION IN MICE FOLLOWING TREATMENT WITH AN IGE-SPECIFIC IMMUNOTOXIN, Molecular immunology, 33(3), 1996, pp. 245-251
SPECIFIC ELIMINATION OF IGE PRODUCTION USING T-CELL LINES EXPRESSING CHIMERIC T-CELL RECEPTOR GENES
Authors: LUSTGARTEN J ESHHAR Z
Citation: J. Lustgarten et Z. Eshhar, SPECIFIC ELIMINATION OF IGE PRODUCTION USING T-CELL LINES EXPRESSING CHIMERIC T-CELL RECEPTOR GENES, European Journal of Immunology, 25(10), 1995, pp. 2985-2991
CONTROL OF MICROWAVE-HEATING OF PERITONEAL-DIALYSIS SOLUTIONS
Authors: DEUTSCHENDORF AF WENK RE LUSTGARTEN J MASON P
Citation: Af. Deutschendorf et al., CONTROL OF MICROWAVE-HEATING OF PERITONEAL-DIALYSIS SOLUTIONS, Peritoneal dialysis international, 14(2), 1994, pp. 163-167
THE USE AND CLINICAL IMPORTANCE OF A SUBSTRATE-SPECIFIC ELECTRODE FORRAPID-DETERMINATION OF BLOOD LACTATE CONCENTRATIONS
Authors: ADUEN J BERNSTEIN WK KHASTGIR T MILLER JA KERZNER R BHATIANI A LUSTGARTEN J BASSIN AS DAVISON L CHERNOW B
Citation: J. Aduen et al., THE USE AND CLINICAL IMPORTANCE OF A SUBSTRATE-SPECIFIC ELECTRODE FORRAPID-DETERMINATION OF BLOOD LACTATE CONCENTRATIONS, JAMA, the journal of the American Medical Association, 272(21), 1994, pp. 1678-1685
Risultati: 1-11 |